All News
Filter News
Found 809,068 articles
-
Tuberculosis Hiding in Bone Marrow Helps Deadly Bacteria Survive, Stanford University School of Medicine Study
1/31/2013
-
Binge Drinking Raises Diabetes Risk, Mount Sinai Medical Center Study
1/31/2013
-
Resonance Health Limited’s FerriScan® R2-MRI Receives FDA Marketing Authorization as the First Imaging Companion Diagnostic Device for Exjade® in Patients With Non-Transfusion-Dependent Thalassemia (NTDT)
1/31/2013
-
Cell Therapeutics, Inc. Announces Data Safety and Monitoring Board Recommendation to Continue the GOG-0212 Phase 3 Clinical Trial of OPAXIOTM as Maintenance Therapy in Ovarian Cancer
1/31/2013
-
NeuroSigma, Inc. Announces Publication of Randomized Controlled Trial of eTNS for Treatment of Drug Resistant Epilepsy in the Leading Journal, Neurology®
1/31/2013
-
CytRx Corporation Receives Recommendation from Data Safety Monitoring Committee to Complete Global Phase 2b Clinical Trial With Tamibarotene as First-Line Treatment for Non-Small-Cell Lung Cancer
1/31/2013
-
Daiichi Sankyo, Inc. and ArQule, Inc. Enroll First Hepatocellular Carcinoma Patient Into Global Phase 3 Trial for Tivantinib
1/31/2013
-
Cerulean Pharma Inc. Announces First Patient Dosed in Randomized Phase 2 Study of CRLX101 in Advanced Small Cell Lung Cancer
1/31/2013
-
Tengion Inc. Announces Clinical Progress for Neo-Urinary Conduit™ Phase 1 Trial and Regulatory Advance for Neo-Kidney Augment™
1/31/2013
-
Arteriocyte, Inc. Receives FDA Approval to Initiate Cellular Therapy Trial for Treatment of Thermal Burn Wounds in Wounded Warriors
1/31/2013
-
OncoEthix Doses First Patient in Its Phase I Trial of OTX015, a BET Bromodomain Inhibitor for the Treatment of Hematologic Malignancies
1/31/2013
-
VG Life Sciences, Inc. Reports Positive Results from First Stage of Ovarian Cancer Clinical Trial Using Sorafenib (Nexavar) Combined With Hydroxychloroquine
1/31/2013
-
PaxVax, Inc. Announces Positive Results for Oral Ad4 Vaccine Technology
1/31/2013
-
Galectin Therapeutics Announces Submission of an Investigational New Drug (IND) Application for the Treatment of Fatty Liver Disease
1/31/2013
-
Velomedix, Inc. Initiates Clinical Trial Enrollment for VELOCITY Pilot Study
1/31/2013
-
IDev Technologies, Inc. Announces Results From Revascularization With Supera on Real World Patients (RESTORE) Study, Demonstrating Positive Clinical Outcomes in Significantly Diseased Patients With Long Lesions
1/31/2013
-
Star Scientific , Inc. Reports Publication of First Peer-Reviewed Article on the Effects of Anatabine in an Animal Model of Multiple Sclerosis
1/31/2013
-
Intersect ENT Initiates U.S. Clinical Study of a Novel In-Office Treatment for Chronic Sinusitis Patients
1/31/2013
-
Allergan Inc. Commences Cash Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc.
1/31/2013
-
BASF Completes Acquisition of Pronova BioPharma
1/31/2013